Diabetes Type 2: Nothing Sweet About ItPage 16 of 16

14. References / Quiz Login or Register

Abraham T, Fox C. (2013, August). Implications of rising prediabetes prevalence. Diabetes Care 36(8):2139–41. Retrieved February 20, 2016 from http://care.diabetesjournals.org/content/36/8/2139.full.

Aguilar M, Bhuket T, Torres S, et al. (2015). Prevalence of the metabolic syndrome in the United States, 2003–2012. JAMA 313(19):1973–74. doi:10.1001/jama.2015.4260. Retrieved February 20, 2016 from http://www.diabetes.org/diabetes-basics/statistics/.

Ahmed, A. (2002). History of Diabetes Mellitus. Saudi Medical Journal 23(4):373–78.

American Academy of Ophthalmology (AAO). (2016). Diabetic Retinopathy. Preferred Practice Pattern Guidelines. Retrieved from http://www.aao.org/preferred-practice-pattern/diabetic-retinopathy-ppp-updated-2016.

American Association of Clinical Endocrinologists (AACE). (2011, Mar/Apr). Medical Guidelines for Clinical Practice for Developing a Diabetes Mellitus Comprehensive Care Plan. In Handelsman Y, et al., Endocrine Practice 17(suppl 2).

American Diabetes Association (ADA). (2015). Diagnosis and classification of diabetes mellitus. Diabetes Care. Retrieved February 20, 2016 from http://www.diabetes.org/diabetes-basics/statistics/.

American Diabetes Association (ADA). (2014). Diabetes Statistics. Retrieved February 20, 2016 from http://care.diabetesjournals.org/content/suppl/2014/12/23/38.Supplement_1.DC1/January_Supplement_Combined_Final.6-99.pdf.

American Diabetes Association (ADA). (2012). The Cost of Diabetes. Retrieved February 21, 2016 from http://www.diabetes.org/advocacy/news-events/cost-of-diabetes.html.

American Dietetic Association (Amer. Diet. Assoc.). (2015). Position of the American Dietetic Association: Health implications of dietary fiber. Journal of the American Dietetic Association 108(10):1716–31.

Anthony DC, Frosch MP, de Girolami U. (2009) Peripheral nerve and skeletal muscle. In V Kumar, AK Abbas, N Fausto, and JC Aster (eds.), Robbins and Cotran: Pathologic Basis of Disease, 8th ed. Philadelphia: Elsevier, Ch. 27.

Basu A, et al. (2009). Effects of type 2 diabetes on insulin secretion, insulin action, glucose effectiveness, and postprandial glucose metabolism. Diabetes Care 32(5): 866–73.

Baranoski S, Ayello E. (2008). Wound Care Essentials: Practice Principles. Baltimore: Wolters Kluwer, Lippincott Williams & Wilkins.

Bolen S, et al. (2007). Comparative effectiveness and safety of oral diabetes medications for adults with type 2 diabetes. Comparative Effectiveness Review. No. 8. AHRQ Publication No. 07-EHC010-EF (July 2007). Retrieved from http://effectivehealthcare.ahrq.gov/healthInfo.cfm?infotype=rr&ProcessID=6&DocID=40.

Boulton AJM, et al. (2008). Comprehensive foot examination and risk assessment. A report of the Task Force of the Foot Care Interest Group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists. Diabetes Care 31(8):1679–85. Retrieved from http://care.diabetesjournals.org/content/31/8/1679.full.

Buse JB, Polonsky KS, Burant CF. (2008). Type 2 diabetes mellitus. In HM Kronenberg, S Melmed, KS Polonsky, and PR Larsen (eds.), Williams Textbook of Endocrinology, 11th ed. Philadelphia: Saunders, Ch. 30.

Centers for Disease Control and Prevention (CDC). (2015). Prediabetes. Retrieved http://www.cdc.gov/diabetes/basics/prediabetes.html.

Centers for Disease Control and Prevention (CDC). (2014). National Diabetes Fact Sheet. Retrieved from http://www.cdc.gov/diabetes/data/statistics/2014statisticsreport.html.

Centers for Disease Control and Prevention. Diabetes National Diabetes Prevention Program (2012). Retrieved http://www.cdc.gov/diabetes/prevention/lifestyle-program/curriculum.html.

Centers for Disease Control and Prevention (CDC). (2013). Obesity in U.S. Adults, BRFSS, 2007. Retrieved from http://www.cdc.gov/nchs/data/databriefs/db131.htm.

Centers for Disease Control and Prevention (CDC). (2005). Quick stats: Lower extremity disease. MMWR 54(13):332. Retrieved from http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5413a4.htm.

Centers for Disease Control and Prevention (CDC). (1972). CDC Public Health Image Library. Atherosclerosis, image ID #846 (Dr. Edwin P. Ewing, Jr.). Retrieved August 20, 2009 from http://phil.cdc.gov/Phil/home.asp.

Cernea S, Raz I. (2011). Therapy in the Early Stage: Incretins. American Diabetes Association. Diabetes Care 34(supp 2):S264–71 doi: 10.2337/dc11-s223. Retrieved from http://care.diabetesjournals.org/content/34/Supplement_2/S264.full.

Cryer PE. (2011). Hypoglycemia. In HM Kronenberg, S Melmed, KS Polonsky, and PR Larsen (eds.), Williams Textbook of Endocrinology, 12th ed. Philadelphia: Saunders, pp. 1552–77.

Diabetes Prevention Program Research Group (2009). Knowler W, et al. 10-year followup of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 374(9702):1677–86. doi: 10.1016/S0140-6736(09)61457-4. Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135022.

Drucker D. (2008). Gastrointestinal hormones and gut endocrine tumors. In HM Kronenberg, S Melmed, KS Polonsky, and PR Larsen (eds.), Williams Textbook of Endocrinology, 13th ed. Philadelphia: Saunders, Ch. 38.

Drucker D, Nauck M. (2006). The incretin system: Glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 368(9548):1696–1705.

Ebbell B. (1937). The Papyrus Ebers, p. 115. Copenhagen and Oxford: Oxford University Press.

Encyclopaedia Britannica. (1911). Diabetes. Encyclopaedia Britannica, 11th ed. 8: 145–46.

Ferrante M. (2007). Endogenous metabolic disorders. In CG Goetz (ed.), Textbook of Clinical Neurology, 3rd ed. Philadelphia: Saunders, Ch. 38.

Food and Drug Administration (FDA). (2015). Diabetes Prevention. Retrieved February 20, 2016 from http://www.fda.gov/ForPatients/Illness/Diabetes/ucm408100.htm.

Food and Drug Administration (FDA). (2011). Lantus (insulin glargine). Retrieved from http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm170089.htm.

Food and Drug Administration (FDA). (2008). Byetta (exenatide). Retrieved May 5, 2016 from http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm079781.htm.

Folberg R. (2009). The eye. In V Kumar, AK Abbas, N Fausto, and JC Aster (eds.), Robbins and Cotran: Pathologic Basis of Disease, 8th ed. Philadelphia: Elsevier, Ch. 29.

Funnell, M., et al. (2007). National standards for diabetes self-management education. Diabetes Care 30(6):1630–37.

Garber A, et al. (2008). Diagnosis and management of prediabetes in the continuum of hyperglycemia. When do the risks of diabetes begin? A consensus statement from the American College of Endocrinology and the American Association of Clinical Endocrinologists. Endocrine Practice 14(7):933–46.

Grant, R., Moore, A., Florez, J. (2009). Genetic architecture of type 2 diabetes: Recent progress and clinical implications. Diabetes Care 32(6):1107–15.

Guangwei L, et al. (2008). The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: A 20-year followup study. Lancet 371:1783–89.

Huether S, McCance K. (2012). Understanding Pathophysiology, 6th ed. Atlanta: Elsevier.

Jenkins N, et al. (2010). Initiating insulin as a part of Treat-to-Target in Type 2 diabetes (4-T) Trial: An interview study of patients’ and health professionals’ experiences. Diabetes Care 33(10) 2178–80.

Joffe D, Yanagisawa R. (2007). Metabolic syndrome and type 2 diabetes: Can we stop the weight gain with diabetes? Medical Clinics of North America 91(6):1107–23.

Kent D, d’Eramo G, Stuart P, et al. (2013). Reducing the risks of diabetes complications through diabetes self-management education and support. Population Health Management 16(2):74–81.

Kitabachi A, Umpierrez G, Murphy M, Kreisberg R. (2006). Hyperglycemic crises in adult patients with diabetes. A consensus statement from the American Diabetes Association. Diabetes Care 29(12):2739–48. Retrieved from http://care.diabetesjournals.org/content/29/12/2739.full.

Lipsky B, et al. (2004). Infectious Diseases Society of America Guidelines: Diagnosis and treatment of diabetic foot infections. Clinical Infectious Diseases 38: 885–910. Retrieved from http://www.idsociety.org/uploadedFiles/IDSA/Guidelines-Patient_Care/PDF_Library/Diabetic%20Foot%20Infection.pdf.

Maitra A. (2009). The endocrine system. In V Kumar, AK Abbas, N Fausto, and JC Aster (eds.), Robbins and Cotran: Pathologic Basis of Disease, 9th ed. Philadelphia: Elsevier.

Miller K, Beck R, Bergenstal R, et al. (2013). Evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin A1c levels in T1D exchange clinic registry participants. American Diabetes Association. Diabetes Care 36(7). Doi:10.2337/dc12-1770. Retrieved from http://care.diabetesjournals.org/content/36/7/2009.short.

Moghissi E, et al. (2009). American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care 32(6):1119–31. Concurrently printed in Endocrine Practice 15(4):353–69.

Monnier L, Colette C, Owens D. (2009). Integrating glycaemic variability in the glycaemic disorders of type 2 diabetes: A move towards a unified glucose tetrad concept. Diabetes/Metabolism Research and Reviews 25(12):393–402. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/19437415.

National Aeronautics and Space Administration (NASA). (2009). RST: Remote Sensing Technology, by Dr. Nicholas M. Short, Sr. Retrieved May 5, 2016 from http://rst.gsfc.nasa.gov/Intro/Part2_26d.html.

National Diabetes Education Program (NDEP). (2015).Changing the Way Diabetes is Treated. Retrieved from http://www.niddk.nih.gov/health-information/health-communication-programs/ndep/about-ndep/15th-anniversary/Documents/NDEP_15th_year.pdf.

National Diabetes Education Program (NDEP). (2014). Diabetes, the Statistics. Retrieved May 5, 2016 from http://www.niddk.nih.gov/health-information/health-statistics/Pages/default.aspx#category=diabetes.

National Eye Institute, NIH (NEI). (2016). Photos, Images, and Videos. Retrieved from https://nei.nih.gov/rop/photos.

National Diabetes Education Program (NDEP). (2015). The Link Between Diabetes and Cardiovascular Disease. Retrieved from http://ndep.nih.gov/media/CVD_FactSheet.pdf.

National Heart, Lung, and Blood Institute, NIH (NHLBI). (2000). The Practical Guide identification, evaluation, and treatment of overweight and obesity in adults. Retrieved http://www.nhlbi.nih.gov/files/docs/guidelines/prctgd_c.pdf.

National Institute of Diabetes and Digestive and Kidney Diseases, (NIH) (2008). Continuous Glucose Monitoring. Retrieved from http://www.niddk.nih.gov/health-information/health-topics/Diabetes/continuous-glucose-monitoring/Pages/index.aspx.

National Institute of Diabetes and Digestive and Kidney Diseases, NIH (NIDDK). (2016). Diabetes Dictionary. Retrieved from http://diabetes.niddk.nih.gov/dm/pubs/dictionary/index.htm.

National Institute of Diabetes and Digestive and Kidney Diseases, NIH (NIDDK). (2008a). National Diabetes Statistics, 2007. Retrieved from http://diabetes.niddk.nih.gov/dm/pubs/control/.

National Institute of Diabetes and Digestive and Kidney Diseases, NIH (NIDDK). (2008b). The Diabetes Control and Complications Trial and Follow-up Study. NIH Publication No. 08-3874. Retrieved from http://www.niddk.nih.gov/about-niddk/research-areas/diabetes/dcct-edic-diabetes-control-complications-trial-follow-up-study/Pages/default.aspx.

National Kidney Foundation–Kidney Disease Outcomes Quality Initiative (NKF-KDOQI). (2007). KDOQI Clinical Practice Guidelines and Clinical Practice Recommendations for Diabetes and Chronic Kidney Disease. American Journal of Kidney Diseases 49(Suppl2): S12–S54.

National Weather Service, NOAA (NWS). (2005). Impairments to vision. Retrieved from http://www.nws.noaa.gov/sec508/htm/blindness.htm.

Nesto R. (2007). Diabetes and heart disease. In P Libby et al. (eds.), Braunwald’s Heart Disease: A Textbook of Cardiovascular Medicine, 10th ed. Philadelphia: Saunders.

O’Connor J, Johnson D, Freund G. (2006). Psychoneuroimmune implications of type 2 diabetes. Neurologic Clinics 24(3):539–59.

Pratt J. (1954). A reappraisal of researchers leading to the discovery of insulin. Journal of History of Medicine 9:281–89.

Strine T, Okoro C, Chapma D, et al. (2005). The impact of formal diabetes education on the preventive health practices and behaviors of persons with type 2 diabetes. Preventative Medicine 41(1):79–84.

Triplitt C. (2014). Pharmacotherapy, 9th ed. New York: McGraw Hill. Also published in Diabetes Care 2003;26(3):881–85.

UK Prospective Diabetes Study Group. (1998). Tight blood pressure control and risk of microvascular and macrovascular complications in type 2 diabetes. UKPDS 38. British Medical Journal 318(7175):29. Retrieved from www.ncbi.nlm.nih.gov/pubmed/9732337.

U.S. Preventive Services Task Force (USPSTF). (2008). Clinical Guidelines. Screening for type 2 diabetes in adults: U.S. Preventive Services Task Force Recommendation Statement. Annals of Internal Medicine 148(11):846–54.

Mensing C. (ed). (2014). The Art and Science of Diabetes Self-Management Education, Desk Reference, 3rd ed. Chicago: AADE.

Wikipedia. (2012a). Glycogen. Retrieved May 5, 2016 from http://en.wikipedia.org/wiki/Glycogen.

Wikipedia. (2012b). Glucagon. Retrieved May 19, 2013 from http://en.wikipedia.org/wiki/Glucagon.

Wild S, Roglic G, Green A, et al.. (2004, May). Diabetes Care 27(5): 1047–53. Retrieved February 20, 2016 from http://care.diabetesjournals.org/content/27/5/1047.abstract.

Zarzycki W, Zieniewicz M. (2005, December). Reproductive disturbances in type 1 diabetic women. Neuro Endocrinology 26(6):733-38.

You've reached the end of this section